While no one’s saying “The end is nigh!” quite yet, there was a clear consensus at this year's event: if pharmacy doesn’t change a lot of things very soon, pharmacists may not like what happens next.
For 50 years, virtually all medical research into psychedelic substances stopped. That research has now been renewed—and these radical therapies are again threatening to upend accepted clinical wisdom